Description     Claims     Drawing  

IT1154655   [0002] 
EP0161534A   [0002]  [0002] 
US7045620B1   [0002] 
WO2006094662A1   [0002] 

Pharmacokinetic study of rifaximin after oral administration in healthy volunteers   [0001]  [0060] 
Pharm Manuf.   [0056] 
J Pharm. Sci.   [0056] 
J. Pharm. Sci.   [0056] 
In vitro activity of rifaximin, metronidazole and vancomycin against clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species   [0062] 
Enteroaggregative Escherichia coli Diarrhea in Travelers: Response to Rifaximin Therapy   [0072] 
Therapy of Travelers' Diarrhea With Rifaximin on Various Continents   [0072] 
N. Engl J Med.   [0072]